SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs REGAL Phase 3 trial reaching its 80th death triggered final analysis, putting the pending GPS survival readout in AML at the center of discussion. The sharp pullback has divided traders: some view it as a shakeout and continue buying, while others warn that the binary results could disappoint.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells agreed all-stock acquisition of Lumentum is driving attention, with LITE holders set to receive a fixed number of Marvell shares rather than cash. Traders are focused on LITEs sharp decline as Marvell shares fall, debating whether the deal undervalues Lumentum and leaves shareholders exposed to Marvells price through a lengthy, approval-dependent closing process.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

UBSs upgrade of Rivian to Buy, citing the recent sell-off as an opportunity ahead of the R2 ramp, is driving attention. Traders are cheering the sharp rise and speculating about a short squeeze, while some remain cautious about the rallys staying power and execution risks.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells announced all-stock acquisition of Lumentum to expand its AI data-center optics and connectivity business is driving discussion. Many traders view the deal as costly and heavily dilutive, contributing to selling in both stocks, while others see strategic value in combining Marvells chips and networking with Lumentums optical technology.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs sharp decline is widely attributed to spillover from Intels disappointing outlook and broader concerns about semiconductor demand and AI spending, rather than a company-specific announcement. Ahead of AMDs earnings, traders disagree over whether Intels weakness signals a wider slowdown or creates an opportunity for AMD to gain share, with bulls calling the selloff overdone and bears worried about weak guidance.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned stock and bond offerings to fund its AI infrastructure buildout are weighing on shares, with traders focused on dilution, rising debt, and the timing of the financing. Some argue the raise was already part of the companys disclosed capital plan and supports growth, while others see it as a sign of mounting funding risk.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is rebounding after its post-earnings selloff, with traders pointing to accelerating AWS growth and strong AI-cloud demand; a Phillip Securities upgrade added support. The debate remains whether those prospects justify heavy AI spending and negative free cash flow, or whether the cash burn and earnings misses warrant caution.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is selling off despite strong Q3 revenue growth and a narrower-than-expected loss, as investors focus on managements lack of quantified guidance, elevated costs, and uncertainty around the Alzheimers agitation launch and path to cash-flow positivity. Some holders view the decline as an overreaction to a solid quarter, while others want clearer evidence of launch traction and spending discipline.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstarts steep selloff and repeated 52-week lows dominate discussion, with traders focused on concerns about its debt, funding access and sensitivity to interest rates and credit conditions. Some see the decline as overdone and point to lending growth, partnerships and a potential bank charter, while others remain skeptical and expect continued pressure.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Attention centers on speculation over when Compass will complete its rolling NDA submission for COMP360 and what the FDA review timeline may mean for the treatments path to market; uncertainty around the update is adding to frustration over the share decline. Usonas separate psilocybin filing has prompted some competitive concern, while other traders argue its MDD focus and nonprofit structure make it a different challenge for Compasss TRD program.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RZLV  I have no clue why the negative reaction to the earnings? Sure margins dropped, but that is short term, core margins are at 90% (which is far more important) They assured the 360m guidance and said specifically it will be hit with &quot;organic growth&quot;! That&#39;s huge, means the acquisition strategy is creating more value than the cost to acquire! They also said there is more to come which will address the economic impact of the Google partnership.
As well in advance talks with other
&quot;hyperscale&quot; companies! So why sell??
Investors have no idea what they own or how to read the signals!

Steven Michael

Fabio

Daniel

Eyal Alon

Shmuel Klein

Rogue Man

sashokd

Yards

Stojan Stamkov

Brett Ayers

Michelle McGonegal

FutureTradehunter

Tolib Nutfulloev

StockTwits for iOS

Rezolve AI Limited

  I have no clue why the negative reaction to the earnings? Sure margins dropped, but that is short term, core margins are at 90% (which is far more important) They assured the 360m guidance and said specifically it will be hit with "organic growth"! That's huge, means the acquisition strategy is creating more value than the cost to acquire! They also said there is more to come which will address the economic impact of the Google partnership.
As well in advance talks with other
"hyperscale" companies! So why sell??
Investors have no idea what they own or how to read the signals!

Hopp

StockTwits Web

Azteca

@Hopp Agreed 100% , but and that&#39;s just today a very fickle. To some extent there was a huge buildup by retailers to this moment. To the point that they thought that not only would they come in on target but another 20 or 30 million on top. The shorts have also been playing around with this and they knew that if they moved out of this range they would lose money and they would lose the opportunity to continue this shenanigans. I&#39;m not sure what it will take to get this above three other than some institutions that begin and taking it there.

StockTwits For Android 

 Agreed 100% , but and that's just today a very fickle. To some extent there was a huge buildup by retailers to this moment. To the point that they thought that not only would they come in on target but another 20 or 30 million on top. The shorts have also been playing around with this and they knew that if they moved out of this range they would lose money and they would lose the opportunity to continue this shenanigans. I'm not sure what it will take to get this above three other than some institutions that begin and taking it there.

@Azteca_ My thoughts… I think RZLV will need to raise capital. Currently have approx $100 mil and a 6 month cash burn of $96 mil. With margins of 48% (albeit) “core”margins are in that 90% range. Currently 398 mil O/S is what I see. 

If they are growing that $220 mil organically I think they will have a reasonable model to acquire financing via non-dilutive options? 

Assuming they achieve there guidance and margins are stable in that 80-90% range and a commitment from the CFO to invest back into the company that reduces that “burn rate” burden significantly. 

So would I say today reports were exactly what I was hoping… NO. But was it enough to keep my optimism till 1st Q of 2027? … so far yes!😜

I definitely am going to watch closely till that Oct 6 presentation and whatever (hyperscalers) may be circling on the horizon. 🤔

Just saying….

 My thoughts… I think RZLV will need to raise capital. Currently have approx $100 mil and a 6 month cash burn of $96 mil. With margins of 48% (albeit) “core”margins are in that 90% range. Currently 398 mil O/S is what I see. 

If they are growing that $220 mil organically I think they will have a reasonable model to acquire financing via non-dilutive options? 

Assuming they achieve there guidance and margins are stable in that 80-90% range and a commitment from the CFO to invest back into the company that reduces that “burn rate” burden significantly. 

So would I say today reports were exactly what I was hoping… NO. But was it enough to keep my optimism till 1st Q of 2027? … so far yes!😜

I definitely am going to watch closely till that Oct 6 presentation and whatever (hyperscalers) may be circling on the horizon. 🤔

Just saying….